proNGF-p75NTR轴在炎症关节中发挥促炎作用:慢性关节炎的新致病机制
研究比较了JIA和RA患者滑液、滑膜组织及细胞中mNGF、proNGF及其受体的表达,发现proNGF而非mNGF是患者滑液中的主要形式,滑膜成纤维细胞是proNGF的主要来源。proNGF通过p75NTR促进炎症因子产生而不诱导IL-10,且p75NTR高表达与关节炎临床症状严重程度相关,提示proNGF-p75NTR轴是慢性关节炎的促炎机制及潜在治疗靶点。
要点
- JIA和RA患者滑液中以proNGF为主,滑膜成纤维细胞是proNGF主要来源。
- proNGF通过p75NTR促进炎症因子产生,不诱导IL-10,并激活p38和JNK通路。
- p75NTR高表达与关节炎临床症状严重程度相关,p75NTR抑制剂或为新的治疗方向。
核心结论
- proNGF-p75NTR轴促进慢性组织炎症,p75NTR抑制剂可能是慢性关节炎的新治疗途径。
研究设计与样本
- 采用实时PCR、蛋白质印迹和ELISA检测JIA和RA患者及对照的滑膜组织与细胞中NGF、proNGF、受体及细胞因子表达。
- 样本包括JIA和RA患者及对照的滑膜液、滑膜组织和细胞。
主要发现
- JIA和RA患者滑液中主要检测到proNGF而非mNGF,滑膜成纤维细胞是炎症滑膜中proNGF的主要来源。
- JIA患者单核细胞中p75NTR是表达最高的NGF受体,而健康供者以TrkA为主。
- proNGF增加炎症细胞因子表达但不增加IL-10,并更强激活p38和JNK通路。
- p75NTR中和抗体或LM11A-31可消除proNGF诱导的患者单核细胞IL-6产生,而抑制TrkA无此效果。
- 关节炎患者中高p75NTR水平与临床症状严重程度相关。
临床怎么用
- p75NTR抑制剂可能成为慢性关节炎的新治疗选择,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify the role of mature nerve growth factor (mNGF), its immature form proNGF and their receptors in arthritis inflammation. METHODS: Real-time PCR, western blot and ELISA were performed to evaluate NGF, proNGF, their receptor and cytokine expression in synovial tissue and cells of patients with juvenile idiopathic arthritis (JIA) and rheumatoid arthritis (RA), and controls. RESULTS: proNGF and not mNGF is the prevalent form measured in synovial fluids of patients with JIA and RA with synovial fibroblasts as a major source of proNGF in the inflamed synoviae. p75NTR, the specific receptor for proNGF, is the NGF receptor most expressed in mononuclear cells of patients with JIA, while TrkA is the prevalent receptor in healthy donors. In ex vivo experiments the effects of proNGF differ from those of mNGF, suggesting that the balance of p75NTR and TrkA expression represents a critical factor in regulating mNGF/proNGF functions, determining which intracellular pathways and biological activities are triggered. Contrary to NGF, proNGF administration increased inflammatory cytokines but not interleukin (IL)-10 expression, inducing a stronger activation of p38 and JNK pathways. proNGF effects depend on its binding to p75NTR, as inhibition of p75NTR with neutralising antibodies or LM11A-31 abolished proNGF-induced production of IL-6 in patients' mononuclear cells, while inhibition of TrkA did not. There is a correlation in patients with arthritis between high p75NTR levels and severity of clinical symptoms. CONCLUSIONS: Our data suggest that an active proNGF-p75NTR axis promotes proinflammatory mechanisms contributing to chronic tissue inflammation, and that the use of p75NTR inhibitors may represent a new therapeutic approach in chronic arthritis.
引用
- Minnone G, Soligo M, Caiello I, et al. ProNGF-p75NTR axis plays a proinflammatory role in inflamed joints: a novel pathogenic mechanism in chronic arthritis. RMD Open. 2017. PMID: 28955492. doi:10.1136/rmdopen-2017-000441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。